In European legal contexts, refers to a specific decision by the European Patent Office (EPO) Boards of Appeal regarding ZTE Corporation.
It is a chimeric GD2-binding monoclonal antibody that helps the immune system identify and destroy neuroblastoma cells. 125516
The decision focused on the configuration of a basic matrix storage module used for storing information and check bits, ensuring specific mathematical inequalities were met to optimize error correction in data transmission. 4. Miscellaneous References In European legal contexts, refers to a specific
It is typically administered in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA). In European legal contexts
It is specifically indicated for the treatment of pediatric patients with high-risk neuroblastoma .